Posts under Tag: OREX
Orexigen Therapeutics stock took a huge hit dropping over 70%, after news was released that the FDA was not going to approve their diet pill Contrave, at least not yet. Going through additional trials to try to get a drug approved, is not a new thing in the pharmaceutical world. The 70% drop, was partly investors and funds, but at [...]
